|
|
||||||||
American Journal of Clinical Nutrition, Vol 63, 354-357, Copyright © 1996 by The American Society for Clinical Nutrition, Inc
ORIGINAL RESEARCH COMMUNICATIONS |
L Mortensen and P Charles
Aarhus Bone and Mineral Research Group, Department of Endocrinology and Metabolism, Aarhus University Hospital, Denmark.
Our aim was to examine a regimen for calcium supplementation because various factors seem to be important for its bioavailability, and to examine the effect of adding vitamin D to the supplement. The participants were 20 healthy women aged 28-59 y (chi: 38 y). During the 3-d periods and 1 d before, the participants were consuming a calcium and energy-balanced diet as similar to their usual daily diet as possible. The study was designed as a randomized, placebo-controlled, partly blinded crossover study divided into four periods of 3 d each: 1) three tablets containing 1000 mg CaCO3/d, 2) three tablets containing 1000 mg CaCO3 plus 5 micrograms (200 IU) vitamin D/d, 3)1 L more milk than in the usual daily diet, and 4) three placebo tablets daily. Bioavailability of the different calcium-supplement regimens were evaluated by changes in 24-h urinary excretion of calcium, phosphate, and magnesium. A significant increase in urinary calcium excretion was found during all periods of supplementation compared with the placebo period (P<0.01). Excretion of calcium in the calcium carbonate period was not significantly higher that that in the milk period, but calcium carbonate plus vitamin D resulted in significantly higher calcium excretion compared with that in the milk period. We conclude that the examined calcium carbonate regimen is at least as good a calcium supplement as milk, and that addition of 600 IU vitamin D/d promptly resulted in an increase in urinary calcium excretion after an increase in calcium absorption, even in healthy women.
This article has been cited by other articles:
![]() |
D. M. Black, A. V. Schwartz, K. E. Ensrud, J. A. Cauley, S. Levis, S. A. Quandt, S. Satterfield, R. B. Wallace, D. C. Bauer, L. Palermo, et al. Effects of Continuing or Stopping Alendronate After 5 Years of Treatment: The Fracture Intervention Trial Long-term Extension (FLEX): A Randomized Trial JAMA, December 27, 2006; 296(24): 2927 - 2938. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Lopez-Huertas, B. Teucher, J. J Boza, A. Martinez-Ferez, G. Majsak-Newman, L. Baro, J. J Carrero, M. Gonzalez-Santiago, J. Fonolla, and S. Fairweather-Tait Absorption of calcium from milks enriched with fructo-oligosaccharides, caseinophosphopeptides, tricalcium phosphate, and milk solids Am. J. Clinical Nutrition, February 1, 2006; 83(2): 310 - 316. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. P. Heaney, M. S. Dowell, C. A. Hale, and A. Bendich Calcium Absorption Varies within the Reference Range for Serum 25-Hydroxyvitamin D J. Am. Coll. Nutr., April 1, 2003; 22(2): 142 - 146. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. U. Karkkainen, C. J. Lamberg-Allardt, S. Ahonen, and M. Valimaki Does it make a difference how and when you take your calcium? The acute effects of calcium on calcium and bone metabolism Am. J. Clinical Nutrition, September 1, 2001; 74(3): 335 - 342. [Abstract] [Full Text] |
||||
![]() |
G. D. Miller, J. K. Jarvis, and L. D. McBean The Importance of Meeting Calcium Needs with Foods J. Am. Coll. Nutr., April 1, 2001; 20(2): 168S - 185. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Gueguen and A. Pointillart The Bioavailability of Dietary Calcium J. Am. Coll. Nutr., April 1, 2000; 19(90002): 119S - 136. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. P. Heaney, M. J. Barger-Lux, M. S. Dowell, T. C. Chen, and M. F. Holick Calcium Absorptive Effects of Vitamin D and Its Major Metabolites J. Clin. Endocrinol. Metab., December 1, 1997; 82(12): 4111 - 4116. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |